236 related articles for article (PubMed ID: 2977026)
1. [New aspects of nuclear medicine diagnosis of kidney function: improved potential by pharmacologic intervention and quantitative analytic procedures].
Kletter K
Wien Klin Wochenschr Suppl; 1988; 177():1-34. PubMed ID: 2977026
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of simultaneous orthoiodohippurate and diethylenetriaminepentaacetic acid captopril renography. The Einstein/Cornell Collaborative Hypertension Group.
Blaufox MD; Fine EJ; Heller S; Hurley J; Jagust M; Li Y; Mann SJ; Pickering TG; Zanzonico P; Zhang CG
J Nucl Med; 1998 Mar; 39(3):522-8. PubMed ID: 9529303
[TBL] [Abstract][Full Text] [Related]
3. Captopril-enhanced scintigraphy using the method of the expected renogram: improved detection of patients with renin-dependent hypertension due to functionally significant renal artery stenosis.
Roccatello D; Picciotto G
Nephrol Dial Transplant; 1997 Oct; 12(10):2081-6. PubMed ID: 9351069
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic imaging in renal vascular diseases: old and new ways. Role of nuclear medicine].
Bagni B; Bagni I; Marzola MC
Arch Ital Urol Nefrol Androl; 1992 Jun; 64 Suppl 2():143-6. PubMed ID: 1411590
[TBL] [Abstract][Full Text] [Related]
5. Captopril-induced changes in MAG3 clearance in patients with renal arterial stenosis and the effect of renal angioplasty.
Müller-Suur R; Tidgren B; Fehrm A; Lundberg HJ
J Nucl Med; 2000 Jul; 41(7):1203-8. PubMed ID: 10914910
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent.
Eshima D; Taylor A
Semin Nucl Med; 1992 Apr; 22(2):61-73. PubMed ID: 1534184
[TBL] [Abstract][Full Text] [Related]
7. Prospective study on captopril renography in hypertensive patients.
Roccatello D; Picciotto G; Rabbia C; Pozzato M; De Filippi PG; Piccoli G
Am J Nephrol; 1992; 12(6):406-11. PubMed ID: 1292339
[TBL] [Abstract][Full Text] [Related]
8. Captopril renography in the diagnosis of renal artery stenosis: accuracy and limitations.
Mann SJ; Pickering TG; Sos TA; Uzzo RG; Sarkar S; Friend K; Rackson ME; Laragh JH
Am J Med; 1991 Jan; 90(1):30-40. PubMed ID: 1986590
[TBL] [Abstract][Full Text] [Related]
9. Renovascular hypertension identified by captopril-induced changes in the renogram.
Geyskes GG; Oei HY; Puylaert CB; Mees EJ
Hypertension; 1987 May; 9(5):451-8. PubMed ID: 2952589
[TBL] [Abstract][Full Text] [Related]
10. The utility of 99mTc-mercaptoacetyltriglycine in captopril renography.
Taylor A; Martin LG
Am J Hypertens; 1991 Dec; 4(12 Pt 2):731S-736S. PubMed ID: 1837994
[TBL] [Abstract][Full Text] [Related]
11. The captopril renogram in percutaneous transluminal angioplasty of the renal arteries.
Meholic AJ; Saddler MC; Hallin GW; Avasthi PS; Tzamaloukas AH
Am J Physiol Imaging; 1992; 7(1):36-41. PubMed ID: 1387792
[TBL] [Abstract][Full Text] [Related]
12. ACE inhibition is superior to angiotensin receptor blockade for renography in renal artery stenosis.
Karanikas G; Becherer A; Wiesner K; Dudczak R; Kletter K
Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):312-8. PubMed ID: 12002704
[TBL] [Abstract][Full Text] [Related]
13. Captopril renal scintigraphy: a new standard for predicting outcome after renal revascularization.
Meier GH; Sumpio B; Setaro JF; Black HR; Gusberg RJ
J Vasc Surg; 1993 Feb; 17(2):280-5; discussion 285-7. PubMed ID: 8433423
[TBL] [Abstract][Full Text] [Related]
14. False-positive captopril renography in patients taking calcium antagonists.
Claveau-Tremblay R; Turpin S; De Braekeleer M; Brassard A; Leblond R
J Nucl Med; 1998 Sep; 39(9):1621-6. PubMed ID: 9744356
[TBL] [Abstract][Full Text] [Related]
15. The effect of percutaneous dilatation of renal arterial stenosis on captopril renography in hypertension.
Anfelter P; Granerus G; Stenström H; Eriksson P; Nyström FH
Blood Press; 2005; 14(6):359-65. PubMed ID: 16403690
[TBL] [Abstract][Full Text] [Related]
16. Captopril renography. Early observations and diagnostic criteria.
Oei HY
Am J Hypertens; 1991 Dec; 4(12 Pt 2):678S-684S. PubMed ID: 1837990
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of 99mTc-MAG3 renal imaging: comparison with 99mTc-DTPA, 99mTc-DMSA and 131I-OIH].
Adachi I; Sueyoshi K; Sugioka Y; Komori T; Ogura Y; Tabuchi K; Nakata Y; Namba R; Tatsu Y; Matsui R
Kaku Igaku; 1994 Feb; 31(2):131-42. PubMed ID: 8121069
[TBL] [Abstract][Full Text] [Related]
18. [Captopril-enhanced renography using 99mTc-DTPA in renovascular hypertensive patients].
Itoh K; Kakizaki H; Kato C; Tsukamoto E; Nakada K; Nagao K; Togashi M; Furudate M
Kaku Igaku; 1990 Apr; 27(4):363-71. PubMed ID: 2198369
[TBL] [Abstract][Full Text] [Related]
19. Differences between 99mTc-DTPA and 99mTc-MAG3 captopril renographies in renovascular hypertension.
Itoh K; Matsui Y; Kato C; Mochizuki T; Kitabatake A
Ann Nucl Med; 1996 May; 10(2):251-5. PubMed ID: 8800457
[TBL] [Abstract][Full Text] [Related]
20. [Overall and separate clearance--renography with and without captopril].
Tondeur M
Rev Med Brux; 1999 Sep; 20(4):A352-5. PubMed ID: 10523921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
